Search research articles
Contact Us
Filters
Showing results (321-330 of 326) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 326 results.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Respirology (Carlton, Vic.)
|
December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
Chest
|
September 27, 2025
Specialist Dietary Intervention in Patients With Fibrotic Interstitial Lung Disease Experiencing Unintentional Weight Loss: A Pilot Randomized Controlled Trial
Rasleen Kahai, Gioele Castelli, Fiammetta Danzo, et al.
The Lancet. Respiratory Medicine
|
September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Dina Visca, Letizia Mori, Vicky Tsipouri, et al.
Leukemia
|
April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Leukemia
|
October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 326) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 326 results.
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Respirology (Carlton, Vic.)
|
December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
Chest
|
September 27, 2025
Specialist Dietary Intervention in Patients With Fibrotic Interstitial Lung Disease Experiencing Unintentional Weight Loss: A Pilot Randomized Controlled Trial
Rasleen Kahai, Gioele Castelli, Fiammetta Danzo, et al.
The Lancet. Respiratory Medicine
|
September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Dina Visca, Letizia Mori, Vicky Tsipouri, et al.
Leukemia
|
April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Leukemia
|
October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
V Madan, P Shyamsunder, L Han, et al.
Page
of 33